Immunotherapy efficacy of strong positive PD-L1 expression non-small cell lung cancer (NSCLC) patients: A systematic review and meta-analysis.

被引：0
|
作者：
Lu, Hongmin
Cui, Longgang
Bai, Yuezong
Zhang, Yuzi
Zhao, Zhengyi
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, Dept Oncol, Renji Hosp, Shanghai, Peoples R China
[2] 3D Med Inc, Med Dept, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21701
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Immunotherapy efficacy of programmed cell death 1 (PD-1) versus programmed death ligand-1 (PD-L1) inhibitors in non-small cell lung cancer (NSCLC) patients: A systematic review and meta-analysis.
    Yang, Danrong
    Cui, Longgang
    Zhang, Yuzi
    Zhao, Zhengyi
    Bai, Yuezong
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [2] Comparing active immunotherapy efficacy of PD-L1 ≥ 50% NSCLC patients: A systematic review and meta-analysis.
    Hu, Yi
    Zhao, Xiaochen
    Bai, Yuezong
    Cui, Longgang
    Zhang, Fan
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [3] PD-L1 expression and genotype in Non-Small Cell Lung Cancer (NSCLC)
    Ansen, S.
    Schultheis, A.
    Hellmich, M.
    Leenders, F.
    Zander, T.
    Michels, S.
    Brockmann, M.
    Stoelben, E.
    Groen, H.
    Timens, W.
    Buettner, R.
    Thomas, R. K.
    Perner, S.
    Wolf, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 5 - 6
  • [4] PD-L1 expression and genotype in non-small cell lung cancer (NSCLC).
    Ansen, Sascha
    Schultheis, Anne Maria
    Hellmich, Martin
    Zander, Thomas
    Brockmann, Michael
    Stoelben, Erich
    Groen, Harry J. M.
    Timens, Wim
    Buettner, Reinhard
    Thomas, Roman K.
    Perner, Sven
    Wolf, Juergen
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [5] Liquid Biopsy Based Monitoring of PD-L1 Expression in Non-Small Cell Lung Cancer (NSCLC) Patients for Immunotherapy
    Singh, G.
    Leong, M.
    Sylvester, S.
    Lee, Y.
    Johnson, C.
    Wu, A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (06): : 1006 - 1006
  • [6] PD-L1 expression and survival in patients with non-small cell lung cancer (NSCLC) in Korea
    Sun, Jong-Mu
    Zhou, Wei
    Choi, Yoon-La
    Choi, So-Jung
    Kim, Se Eun
    Wang, Zhen
    Dolled-Filhart, Marisa
    Emancipator, Kenneth
    Weiner, Russell
    Park, Minjin
    Kim, Hong Kwan
    Choi, Yong Soo
    Shim, Young Mog
    Kim, Jhingook
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [7] Incidence risk of PD-1/PD-L1 related diarrhea in non-small cell lung cancer (NSCLC) patients: a systematic review and meta-analysis
    Zhang, Caiqing
    Zhang, Shuisheng
    Xu, Deguo
    Liu, Rujun
    Zhu, Qingshan
    Zhao, Yi
    Mao, Yantao
    Tian, Yuan
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 3957 - 3969
  • [8] PD-L1 Expression in Patients with Non-small Cell Lung Cancer
    Masago, Katsuhiro
    Fujita, Shiro
    Hata, Akito
    Okuda, Chiyuki
    Kaji, Reiko
    Katakami, Nobuyuki
    Hirata, Yukio
    ANTICANCER RESEARCH, 2017, 37 (05) : 2269 - 2274
  • [9] The association of PD-L1 expression with the efficacy of antiPD-1/PD-L1 immunotherapy and survival of non-small cell lung cancer patients: a meta-analysis of randomized controlled trials
    Xu, Yangyang
    Wan, Bing
    Chen, Xi
    Zhan, Ping
    Zhao, Yuan
    Zhang, Tianli
    Liu, Hongbing
    Afzal, Muhammad Zubair
    Dermime, Said
    Hochwald, Steven N.
    Hofman, Paul
    Borghaei, Hossein
    Lin, Dang
    Lv, Tangfeng
    Song, Yong
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 (04) : 413 - +
  • [10] Efficacy and safety of the PD-1/PD-L1 in metastasic non-small cell lung cancer (NSCLC)
    Gonzalez-Velez, Abel
    Pino-Villareal, Luis E.
    Barrera-Barinas, Alexander
    Castillo-Niuman, Andrea
    Tolosa-Perez, Erica N.
    Castelblanco, Diana, I
    Pinzon-Florez, Carlos E.
    Yomayusa, Nancy
    GACETA MEXICANA DE ONCOLOGIA, 2021, 20 (03): : 111 - 123
12345